Across 157 enterprises, organizations are granting AI agents more autonomy while trusting the evaluations meant to gate that autonomy less. Half have already shipped an agent that passed their internal evaluations and then failed a customer in production; only one in twenty fully trusts automated evaluation today; and the most-cited weakness is that evaluations do not align with real-world outcomes. Yet two-thirds already allow, or are actively engineering toward, deploying agent changes to production on automated evaluation alone — with no human in the loop. The result is an evaluation gap — the distance between how much autonomy enterprises are handing their agents and how far they trust the tests that are supposed to catch the failures.
This wave of VentureBeat Pulse Research examines how technical leaders measure agent performance: which reliability and evaluation platforms they use, how they select and trust them, what breaks in production, and how far they are willing to let agents run without a human in the loop.
The central finding is an evaluation gap — the distance between the autonomy enterprises are granting their agents and the trust they place in the evaluations meant to govern it. Half of organizations (50%) have, in the past year, deployed an agent or LLM feature that passed their internal evaluations and then caused a customer-facing failure, and a quarter have seen it happen more than once. Trust in the tests themselves is thin: only 5% say they fully trust automated evaluation today, and the single most-cited limitation is that evaluations align poorly with real-world outcomes (29%). Enterprises are discovering that a passing eval is not the same as a working agent.
What makes the gap consequential is the direction of travel. Two-thirds of organizations (66%) already permit fully automated, zero-human-in-the-loop deployment for low-risk agents (34%) or are actively engineering their pipelines to allow it within twelve months (33%). At the same time, the evaluation stack that would have to earn that trust is fragmented and immature: the most common primary tools are the model providers’ native evals, tied with having no dedicated tooling at all (17% each); and only about a quarter of enterprises run real-time quality checks on live production traffic. The autonomy is arriving faster than the assurance.
Methodology
VentureBeat fielded this survey as part of its ongoing Pulse Research series, this survey — the Agentic Reliability & Evals tracker — focused on how technical leaders evaluate agent performance and reliability. Responses are filtered to organizations with 100 or more employees (n=157), drawn from a single survey in June 2026; because this is one wave rather than a pooled multi-month sample, the report reads cross-sectionally and does not infer month-over-month trends. Where questions were multiple-select, those shares can sum to more than 100%.
By role the sample is senior and buyer-credible: 38% are final decision-makers for AI purchases and another 34% recommenders or influencers. Product and program managers (15%), consultants and advisors (10%), directors of engineering/IT (8%), and CIOs/CTOs/CISOs (8%) lead the named titles, alongside a large “Other” function (37%). By organization size the sample is mid-market-weighted: 100–499 (37%) and 500–2,499 (27%) employees lead, with 2,500–9,999 (20%), 10,000–49,999 (10%), and 50,000+ (6%) above them. Technology/Software is the largest industry at 23%, followed by Retail/Consumer (15%), Healthcare/Life Sciences (12%), and Manufacturing (10%).
At 157 respondents the sample is large enough to read directionally but should be treated as a directional signal rather than a precise measurement; it is self-selected and is not a probability sample. It skews toward the mid-market, so it is best read as the view from organizations actively standing up agent evaluation practices rather than from the largest operators.
Note: This survey was rebuilt for the June wave from the earlier “LLM observability and evaluations” survey; because the questions and sample differ, no comparisons are made to the April–May data.
Half have shipped an agent that passed evals, then failed a customer
We asked whether, in the past 12 months, organizations had deployed an agent or LLM feature that passed their internal evaluations but then caused a customer-facing failure. Half of those that run evaluations had.
Finding 1 — A passing eval is not a working agent
24%
yes, more than once — a recurring gap between evaluation and reality
36%
no such production failure identified
8%
don’t run pre-deployment evaluations; a further 6% don’t track this or can’t say
This is the report’s defining number. Half of organizations (50%) have shipped an AI feature that cleared their internal evaluations and then failed in front of a customer — an incorrect output, a broken workflow, or a quality incident — and a quarter have seen it happen more than once. Only 36% report no such failure, and the remainder either run no pre-deployment evaluations (8%) or don’t track the root cause closely enough to know (6%). The failure is precise and expensive: the evaluation said the agent was ready, and it was not. Everything that follows — how enterprises trust their evals, what they monitor, and how much autonomy they grant — is shaped by this experience.
Finding 2: Almost no one fully trusts automated evaluation
The top complaint: Evals don’t match real-world outcomes
We asked which limitation most reduces trust in automated agent evaluations today. Only a sliver of enterprises had no complaint at all.
Finding 2 — Almost no one fully trusts automated evaluation
29%
poor alignment with real-world outcomes — the leading limitation
21%
evaluation bias or inconsistency
18%
lack of explainability
17%
data leakage or privacy concerns
11%
tooling immaturity; just 5% say they fully trust automated evaluation today
Trust in automated evaluation is scarce, and specific. Only 5% of organizations say they fully trust automated evaluation as it stands — meaning 95% name a limitation that holds them back. The most common, at 29%, is the one that most directly explains Finding 1: evaluations align poorly with real-world outcomes, passing agents that later fail. Bias or inconsistency (21%) and a lack of explainability (18%) follow — enterprises cannot always tell why an evaluation reached its verdict — and 17% cite data-leakage or privacy concerns in the evaluation process itself. The tests meant to certify agents are not yet trusted to certify them, which is precisely why the autonomy trajectory in Finding 3 is so striking.
Finding 3: The autonomy ceiling is rising anyway
Two-thirds already allow, or are building toward, zero-human deployment
We asked whether organizations would let an autonomous agent deploy a code or system change to production on automated evaluation results alone, with no human-in-the-loop validation. The trajectory runs straight through the trust gap.
Finding 3 — The autonomy ceiling is rising anyway
34%
yes — already allowed for specific low-risk agents or changes
33%
no — but actively engineering the pipeline to allow it within 12 months
22%
no — and do not expect to permit fully automated deployment for the foreseeable future
8%
not applicable — they don’t deploy autonomous agents; 3% don’t know
Here is the paradox at the heart of the report. Even though almost no one fully trusts automated evaluation (Finding 2), two-thirds of organizations (66%) either already allow zero-human-in-the-loop deployment for low-risk agents (34%) or are actively engineering their pipelines to permit it within a year (33%). Only 22% rule it out for the foreseeable future. The direction is unambiguous: enterprises are moving to let evaluations gate production autonomously — removing the human check — at the same moment they say those evaluations don’t reliably match reality. The autonomy ceiling is rising faster than the assurance beneath it, which is the mechanism by which the false-confidence failures of Finding 1 will scale rather than shrink.
Notably, the autonomy bet is not just a small company phenomenon. Splitting the sample by company size, larger enterprises are slightly further down the path toward zero human review than smaller companies (70% versus 64%) and slightly more likely to have shipped an evaluation-passing agent that then failed a customer (54% versus 48%). The assumption that large, regulated organizations are holding the human in the loop longest is, in this sample, backwards. To be sure, these are directional figures, since the survey was not a huge sample — 57 respondents from companies with 2,500+ employees and 100 from companies smaller than that.
Finding 4: The evaluation stack is fragmented and provider-led
Provider-native evals lead — tied with no dedicated tool at all
We asked which agent reliability or evaluation platform enterprises primarily use today. The market has no clear leader — and a large share has nothing dedicated.
Finding 4 — The evaluation stack is fragmented and provider-led
17%
use OpenAI Developer Platform native evals/traces — narrowly the most common tool
17%
use no dedicated agent reliability or evaluation tooling at all
13%
Anthropic Claude Console native evals
12%
Confident AI (DeepEval); 11% custom in-house tooling
8%
Braintrust; the pure-play specialists (LangSmith, Weave, Promptfoo, Langfuse, Arize) sit in low single digits
The evaluation layer is early and unconsolidated. Provider-native tooling leads — OpenAI’s native evals and traces (17%) and Anthropic’s Claude Console evals (13%) together outweigh any independent platform — but it is tied at the top by a striking answer: 17% of enterprises use no dedicated agent-evaluation tooling at all, a notable gap for organizations shipping agents to customers. The specialist evaluation vendors — DeepEval (12%), Braintrust (8%), LangSmith, Weave, Promptfoo, Langfuse, Arize — are scattered across single to low double digits, and 11% have built their own. No independent platform has yet become the category standard, which leaves most enterprises evaluating agents with provider-native tools, home-grown scripts, or nothing.
Finding 5: Production monitoring rarely watches output quality
Only a quarter run real-time quality checks on live traffic
Production monitoring for an AI agent can watch two very different things. It can watch whether the system is functioning — is the agent up and responding, did each request complete, how fast, at what cost, with any errors. Or it can watch whether the agent’s output is correct — automated checks that evaluate the content of each answer as it goes out: did the agent give the right answer, take the right action, stay within policy. The distinction matters because a confidently wrong answer is invisible to the first kind of monitoring: the request completes, the response is fast, no error is thrown, and every functioning-metric reads healthy. We asked organizations which kind their live production monitoring is built for today.
Finding 5 — Production monitoring rarely watches output quality
25%
transaction trace logging — infrastructure spans, token counts, raw I/O for post-hoc debugging
25%
gateway infrastructure tracking — latency, error rates, and cost at the API layer, not output quality
23%
inline quality assertions — real-time judges/guardrails on live traffic that alert on quality drops
10%
ad-hoc review of live output quality; a further 17% don’t know or say it isn’t their area
Grouped by what is actually being watched, the split is stark: 51% of organizations monitor only whether the agent is functioning, while 23% monitor whether its answers are right. Counting the ad-hoc reviewers and the don’t-knows, roughly three-quarters of organizations run no automated, real-time evaluation of output correctness in production — they can see that the system is up and what it costs, and they are taking the correctness of its answers on faith. That blind spot is the runtime counterpart to the pre-deployment gap in Finding 1: the same organizations engineering the human out of the deployment decision mostly cannot see, in real time, when the deployed agent starts getting things wrong.
Finding 6: Bought on cost, measured on consistency
Price and integration drive selection; evaluation consistency is the goal
We asked what most influenced enterprises’ choice of an evaluation vendor, and what they treat as their primary measure of success. Both answers are pragmatic.
Finding 6 — Bought on cost, measured on consistency
28%
chose their vendor primarily on the cost of evaluations — the top selection factor
27%
on ease of integration; 24% on evaluation accuracy
36%
name evaluation consistency as their primary success metric — the single most-cited goal
19%
measure success by speed of experimentation; 18% by reduction in failures or regressions
Enterprises buy evaluation tooling on economics and trust it on repeatability. Cost of evaluations (28%) narrowly leads selection, just ahead of ease of integration (27%) and evaluation accuracy (24%) — breadth of observability (13%) and vendor roadmap (4%) matter far less. On what success looks like, more than a third (36%) name evaluation consistency — getting the same verdict on the same behavior every time — well ahead of speed of experimentation (19%), reduction in failures (18%), production visibility (13%), and compliance (11%). The emphasis on consistency is telling: before enterprises can trust an evaluation’s verdict, they need it to be stable — the very property whose absence (bias and inconsistency) ranked among the top trust limitations in Finding 2. Satisfaction with current tooling is only moderate, averaging 3.8 on a five-point scale across overall satisfaction, ease of implementation, and value for money.
Finding 7: The next dollar goes to humans and observability
Investment is flowing to oversight, not just automation
We asked which reliability and evaluation investment will grow most over the next year. The money is going toward watching agents more closely — including with people.
Finding 7 — The next dollar goes to humans and observability
30%
production observability tooling — the top growth area
26%
human review workflows
20%
safety and policy evaluation
16%
automated evaluation pipelines
8%
say their budget is not increasing
The second-largest planned investment — behind only production observability — is human review workflows, at 26%. Read against Finding 1, that is the report’s quietest contradiction: at the same moment two-thirds of enterprises are engineering the human out of the deployment decision, more of them plan to grow spending on human reviewers (26%) than on the automated evaluation pipelines (16%) that would replace them. The zero-human trajectory and the human-review budget are rising in the same companies at the same time. Indeed, only 8% report that their budget is not increasing.
Taken together, enterprises are hedging: building toward autonomy while spending to watch agents more closely and keep humans available for the calls that automated evaluation cannot yet be trusted to make.
Finding 8: A tooling reshuffle is coming
Nearly two-thirds plan to adopt or switch platforms within a year
We asked whether enterprises plan to adopt a new, additional, or replacement evaluation platform, and which they are considering. Few intend to stand pat.
Finding 8 — A tooling reshuffle is coming
36%
have no plans to change
31%
plan to adopt or switch within the next 0–3 months
The evaluation market is wide open. While 36% have no plans to change, a clear majority (64%) intend to adopt a new, additional, or replacement platform within twelve months, and 31% within the next quarter. The consideration set points where current usage is thinnest: Confident AI’s DeepEval leads what enterprises are evaluating (20%), ahead of OpenAI’s native evals (13%) and Braintrust (9%) — the open-source specialists drawing more interest than their present footprint.
Given that so many enterprises today rely on provider-native tools or nothing at all (Finding 4), this is less a defection than a first real wave of tooling adoption — the moment the evaluation layer starts to consolidate. Which platforms earn that trust, in a market where almost no one trusts automated evaluation yet, is the open question this series will keep tracking.
The bottom line: An evaluation gap that autonomy will widen, not close
Organizations with 100 or more employees are granting AI agents more independence than they trust their evaluations to support. Half have already shipped an agent that passed its evals and then failed a customer; almost none fully trust automated evaluation, chiefly because it doesn’t match real-world outcomes; and most watch production for uptime and cost rather than for whether the agent’s answers are right. Yet two-thirds already allow, or are actively building toward, deploying to production on automated evaluation alone.
The vendor market is early and unsettled: the most common primary evaluation tools are provider-native evals, tied with no dedicated tooling at all, and a clear majority plan to adopt or switch platforms within the year. Encouragingly, the next dollar is going to observability and — pointedly — human review, suggesting enterprises sense the gap even as they engineer past it. At 157 respondents in a single wave this is a directional read, skewed toward the mid-market — but the direction is clear: autonomy is being granted on the strength of evaluations that the people granting it do not yet trust. The evaluation gap is not a coverage problem that more tests alone will close; it is a problem of evaluations that reflect reality and can be trusted to gate it. The open question for later waves is whether assurance catches up to autonomy — or whether the false-confidence failures move from customer incidents into changes that deploy themselves.
Based on survey responses from 157 qualified enterprise respondents (100+ employees), drawn from a single June 2026 wave. This is a directional read rather than a precise measurement — the sample is self-selected, not a probability sample, and skews toward the mid-market. Respondents include product and program managers, consultants and advisors, directors of engineering/IT, and CIOs/CTOs/CISOs, among other functions, across technology/software, retail/consumer, healthcare/life sciences, manufacturing, and other industries.
